Topic update: this appraisal has not been defined as therapeutically critical. The appraisal will therefore be paused. At this stage, we are unable to provide alternative timelines as to when the appraisal may be re-started but we will provide an update when this information is available.
| Status | Schedule affected by COVID-19 |
| Process | STA 2018 |
| ID number | 1440 |
Provisional Schedule
| Committee meeting: 1 | 04 August 2021 |
Project Team
| Project lead | Shonagh D'Sylva |
Email enquiries
- If you have any queries please email TAteam2@nice.org.uk
| Evidence Review Group / Assessment Group | Health Economics Research Unit and Health Services Research Unit, University of Aberdeen |
Consultees
| Companies sponsors | Medtronic (TYRX Absorbable Antibacterial Envelope) |
| Others | Department of Health and Social Care |
| NHS England | |
| NHS Leicester City CCG | |
| NHS Newham CCG | |
| Welsh Government | |
| Patient carer groups | Arrhythmia Alliance |
| Atrial Fibrillation Association | |
| British Cardiac Patients Association | |
| British Heart Foundation | |
| Blood Pressure UK | |
| Cardiac Risk in Young Children | |
| Cardiomyopathy UK | |
| Cardiovascular Care Partnership | |
| HEART UK | |
| Muslim Council of Britain | |
| Pumping Marvellous Foundation | |
| Royal College of Surgeons Patient Liaison Group | |
| The Ashley Jolly SADS UK Trust | |
| The Sepsis Trust | |
| Somerville Foundation | |
| South Asian Health Foundation | |
| Specialised Healthcare Alliance | |
| UK Health Forum | |
| Professional groups | Association of Anaesthetists |
| Association of Surgeons of Great Britain and Ireland | |
| British Association for Nursing in Cardiovascular Care | |
| British Cardiovascular Society | |
| British Geriatrics Society | |
| British Heart Foundation | |
| British Heart Rhythm Society | |
| British Nuclear Cardiology Society | |
| The British Society for Heart Failure | |
| Royal College of Emergency Medicine | |
| Royal College of General Practitioners | |
| Royal College of Anaesthetists | |
| Royal College of Nursing | |
| Royal College of Pathologists | |
| Royal College of Physicians | |
| Royal College of Surgeons of England | |
| Royal Pharmaceutical Society | |
| Royal Society of Medicine | |
| Society for Cardiological Science and Technology | |
| Society for Cardiothoracic Surgery in Great Britain and Ireland | |
| UK Health Forum | |
| Society of Cardiothoracic Surgeons | |
| UK Clinical Pharmacy Association |
Commentators
| Associated public health groups | Public Health England |
| Public Health Wales | |
| Comparator companies | Accord UK (vancomycin) |
| Flynn Pharma (vancomycin) | |
| Sanofi (gentamicin, teicoplanin) | |
| Syntacoll GmbH (Collatamp G) | |
| Wockhardt UK (flucloxacillin, gentamicin, vancomycin) | |
| General commentators | All Wales Therapeutics and Toxicology Centre |
| Allied Health Professionals Federation | |
| Association of British Healthcare Industries | |
| Board of Community Health Councils in Wales | |
| British National Formulary | |
| Care Quality Commission | |
| Department of Health, Social Services and Public Safety for Northern Ireland | |
| EUCOMED | |
| Healthcare Improvement Scotland | |
| Medicines and Healthcare products Regulatory Agency | |
| National Association of Primary Care | |
| National Pharmacy Association | |
| NHS Alliance | |
| NHS Confederation | |
| NHS Supply Chain | |
| Royal College of Physicians of Edinburgh | |
| Royal College of Surgeons of Edinburgh | |
| Scottish Medicines Consortium | |
| Welsh Health Specialised Services Committee | |
| Relevant research groups | British Society for Cardiovascular Research |
| Cardiac and Cardiology Research Dept, Barts | |
| Cochrane Heart Group | |
| National Centre for Cardiovascular Preventions and Outcomes | |
| Heart Research UK | |
| MRC Clinical Trials Unit | |
| National Institute for Health Research | |
| Wellcome Trust |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 04 May 2021 | Please note that due to operational reasons the committee meeting (scheduled 9 June 2021) has been delayed. The committee meeting has now been scheduled to 4 August 2021. |
| 05 May 2020 | Schedule affected by COVID-19. Topic update: this appraisal has not been defined as therapeutically critical. The appraisal will therefore be paused. At this stage, we are unable to provide alternative timelines as to when the appraisal may be re-started but we will provide an update when this information is available. |
| 12 November 2019 | The Technology appraisal (ID1440) for TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices has been suspended. Medtronic have offered a Patient Access Scheme, however, NHS England recently provided feedback that this proposal could not be operationalised. Consequently Medtronic requested NICE to suspend the Technology Appraisal while other options are explored. |
| 29 March 2019 | Invitation to participate |
| 29 March 2019 | In progress. The invitation to participate went out to the stakeholders. |
| 13 September 2018 (10:00) | Scoping workshop (London) |
| 23 July 2018 - 20 August 2018 | Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance